- Home
- SPCB vs CRIS Comparison
SPCB vs CRIS Comparison
Compare SPCB & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- CRIS
- Stock Information
- Founded
- SPCB 1988
- CRIS 2000
- Country
- SPCB Israel
- CRIS United States
- Employees
- SPCB N/A
- CRIS N/A
- Industry
- SPCB Semiconductors
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPCB Technology
- CRIS Health Care
- Exchange
- SPCB Nasdaq
- CRIS Nasdaq
- Market Cap
- SPCB 53.3M
- CRIS 21.3M
- IPO Year
- SPCB N/A
- CRIS 2000
- Fundamental
- Price
- SPCB $9.99
- CRIS $1.75
- Analyst Decision
- SPCB Strong Buy
- CRIS Strong Buy
- Analyst Count
- SPCB 1
- CRIS 2
- Target Price
- SPCB $18.00
- CRIS $16.50
- AVG Volume (30 Days)
- SPCB 189.7K
- CRIS 128.9K
- Earning Date
- SPCB 08-14-2025
- CRIS 07-31-2025
- Dividend Yield
- SPCB N/A
- CRIS N/A
- EPS Growth
- SPCB N/A
- CRIS N/A
- EPS
- SPCB 1.89
- CRIS N/A
- Revenue
- SPCB $27,831,000.00
- CRIS $11,202,000.00
- Revenue This Year
- SPCB $2.73
- CRIS N/A
- Revenue Next Year
- SPCB $22.87
- CRIS $10.67
- P/E Ratio
- SPCB $5.33
- CRIS N/A
- Revenue Growth
- SPCB 2.90
- CRIS 14.17
- 52 Week Low
- SPCB $2.55
- CRIS $1.02
- 52 Week High
- SPCB $18.95
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- SPCB 50.23
- CRIS 34.36
- Support Level
- SPCB $9.66
- CRIS $2.11
- Resistance Level
- SPCB $11.14
- CRIS $2.48
- Average True Range (ATR)
- SPCB 0.71
- CRIS 0.21
- MACD
- SPCB -0.20
- CRIS -0.06
- Stochastic Oscillator
- SPCB 30.81
- CRIS 17.36
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.